chr16-84155744-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_178452.6(DNAAF1):c.736G>A(p.Asp246Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00153 in 1,614,010 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_178452.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAAF1 | NM_178452.6 | c.736G>A | p.Asp246Asn | missense_variant | 5/12 | ENST00000378553.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAAF1 | ENST00000378553.10 | c.736G>A | p.Asp246Asn | missense_variant | 5/12 | 1 | NM_178452.6 | P1 | |
DNAAF1 | ENST00000567918.5 | c.736G>A | p.Asp246Asn | missense_variant, NMD_transcript_variant | 5/7 | 1 | |||
DNAAF1 | ENST00000570298.5 | n.890G>A | non_coding_transcript_exon_variant | 5/11 | 2 | ||||
DNAAF1 | ENST00000563093.5 | c.736G>A | p.Asp246Asn | missense_variant, NMD_transcript_variant | 5/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00595 AC: 904AN: 152038Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00178 AC: 447AN: 251418Hom.: 7 AF XY: 0.00141 AC XY: 192AN XY: 135892
GnomAD4 exome AF: 0.00106 AC: 1554AN: 1461854Hom.: 14 Cov.: 32 AF XY: 0.000993 AC XY: 722AN XY: 727232
GnomAD4 genome AF: 0.00598 AC: 910AN: 152156Hom.: 6 Cov.: 32 AF XY: 0.00582 AC XY: 433AN XY: 74380
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2024 | - - |
Primary ciliary dyskinesia 13 Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Aug 21, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at